These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1872 related articles for article (PubMed ID: 9632964)

  • 1. Medicine and the pharmaceutical industry: what's right, what's wrong, and what's to come.
    Tan SY
    Singapore Med J; 1998 Mar; 39(3):91-5. PubMed ID: 9632964
    [No Abstract]   [Full Text] [Related]  

  • 2. America's other drug problem: how the drug industry distorts medicine and politics.
    Relman AS; Angell M
    New Repub; 2002 Dec; 227(25):27-41. PubMed ID: 12561803
    [No Abstract]   [Full Text] [Related]  

  • 3. Prescription drug pricing: the consumer perspective.
    Searing A
    N C Med J; 2003; 64(6):300-2. PubMed ID: 14983625
    [No Abstract]   [Full Text] [Related]  

  • 4. The economics of prescription drug prices, government intervention, and the importation of drugs from Canada.
    Openshaw MS
    Nurs Econ; 2005; 23(6):307-11, 279. PubMed ID: 16459902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
    Brand R
    State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
    [No Abstract]   [Full Text] [Related]  

  • 6. Forecasting the future.
    Tecnologica; 1999 Dec; ():1, 3-6, 14-5. PubMed ID: 10848110
    [No Abstract]   [Full Text] [Related]  

  • 7. What's happening with pharmaceuticals? And how will it impact your practice?
    Williams B
    Tenn Med; 2005 May; 98(5):213-6. PubMed ID: 15934528
    [No Abstract]   [Full Text] [Related]  

  • 8. Managed care cost containment involving prescription drugs. American Medical Association, Council on Ethical and Judicial Affairs.
    Food Drug Law J; 1998; 53(1):25-34. PubMed ID: 11795334
    [No Abstract]   [Full Text] [Related]  

  • 9. Drugs: budget busters or cost cutters in future health care?
    Egger E
    Health Care Strateg Manage; 1999 Mar; 17(3):1, 22-3. PubMed ID: 10351640
    [No Abstract]   [Full Text] [Related]  

  • 10. Marketing pharmaceutical products to physicians. Sales reps influence physicians' impressions of the industry.
    Creyer EH; Hrsistodoulakis I
    Mark Health Serv; 1998; 18(2):34-8. PubMed ID: 10180333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health plans keeping drug cost increases in check with programs that promote generics.
    Capitation Manag Rep; 2002 Jul; 9(7):101-3, 97. PubMed ID: 12164057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health care reform and the pharmaceutical industry.
    Mossinghoff GJ
    Health Care Manag; 1994 Aug; 1(1):187-96. PubMed ID: 10152353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State and federal government mandates are changing the face of pharmacy management.
    Giaquinta D
    Manag Care Interface; 2001 May; 14(5):50-2. PubMed ID: 11385948
    [No Abstract]   [Full Text] [Related]  

  • 14. Why drugs cost so much.
    Noonan D
    Newsweek; 2000 Sep; 136(13):22-30. PubMed ID: 11183315
    [No Abstract]   [Full Text] [Related]  

  • 15. Prescription drug pushers. Patents and ads are the big reasons pills are priced like perfume and caviar.
    Sherrid P
    US News World Rep; 2000 Oct; 129(17):40-2. PubMed ID: 11184929
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of pharmaceutical direct advertising: opportunities and obstructions.
    Pinto MB; Pinto JK; Barber JC
    Health Mark Q; 1998; 15(4):89-101. PubMed ID: 10185455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Parallel import of drugs for better and for worse].
    Krabbe U
    Ugeskr Laeger; 2004 Feb; 166(7):611. PubMed ID: 15005051
    [No Abstract]   [Full Text] [Related]  

  • 18. If foreign drug prices go up, will U.S. prices come down?
    Med Health; 2003 Dec; 57(45):2-4. PubMed ID: 14723168
    [No Abstract]   [Full Text] [Related]  

  • 19. What's the benefit? A new federal Medicare drug plan stimulates independent actions and new ideas, but what's the future role for states?
    Cauchi R
    State Legis; 2004; 30(7):28-33. PubMed ID: 15241878
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of pharmaceutical companies.
    Parnes B
    J Fam Pract; 2000 Dec; 49(12):1154-5. PubMed ID: 11132068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 94.